Small Animal

WVC 90th Annual Conference

(SA35) Why Do We Need Another Marker of GFR? Incorporating SDMA into the Clinics

Wednesday, March 7
8:00 AM - 8:50 AM
MBCC, Mandalay Bay I, Level 2

CE Credits: 1

This session will discuss limitations of serum creatinine and describe recent studies on SDMA, including an overview of patient results obtained thus far. Case examples will be used to demonstrate interpretation of SDMA in the context of a clinical patient, with emphasis on SDMA-creatinine mismatches.

Mary B. Nabity

Assistant Professor
Texas A&M University

Dr. Mary Nabity is an assistant professor and board-certified clinical pathologist at Texas A&M University College of Veterinary Medicine & Biomedical Sciences. She completed her undergraduate degree from the University of Nebraska and received her DVM from Cornell University, followed by an internship and residency at Texas A&M University. She completed a PhD in veterinary pathology, with a focus on urinary proteins as biomarkers of chronic kidney disease in dogs. She is continuing to explore biomarkers of renal disease and mechanisms for renal disease progression.

Presentation(s):

Send Email for Mary Nabity


Assets

(SA35) Why Do We Need Another Marker of GFR? Incorporating SDMA into the Clinics

Notes

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Why Do We Need Another Marker of GFR? Incorporating SDMA into the Clinics